| Literature DB >> 31489343 |
Takahiro Abe1, Tomoya Sato2, Tetsuya Yoda3, Kazuto Hoshi1.
Abstract
INTRODUCTION: The central regulatory system that generates biological rhythms is regulated by circadian clock genes expressed by cells in the suprachiasmatic nucleus. Signals from this system are converted to adrenocortical hormones through the sympathetic nervous system and transmitted to peripheral organs. Another system releases glucocorticoids (GCs) in response to stress through the HPA-axis. Here we investigated the second messenger GC, which is shared by these systems and influences the expression of circadian clock genes of cells of the musculoskeletal system and in viable bone tissue.Entities:
Keywords: ACTH, adrenocorticotropic hormone; ASPS, advanced sleep phase syndrome; BMSCs, bone marrow stem cells; BV/TV, bone volume/tissue volume; CRH, corticotropin-releasing hormone; Circadian rhythm; ES/BS, Eroded surface/ Bone surface; G.P.Th, growth plate thickness; Glucocorticoids; HPA-axis, hypothalamic-pituitary-adrenal-axis; MS/OS, Mineralizing surface/Osteoid surface; OS/BS, Osteoid surface/ Bone surface; OV/BV, Osteoid volume/ Bone volume; OV/TV, Osteoid volume/Tissue volume; Period circadian clock 2 gene; Second messenger; Tb.Th, Trabecular thickness
Year: 2019 PMID: 31489343 PMCID: PMC6715891 DOI: 10.1016/j.reth.2019.07.006
Source DB: PubMed Journal: Regen Ther ISSN: 2352-3204 Impact factor: 3.419
RT-PCR primers.
| Genes | Upstream (5′-3′) | Downstream (5′-3′) |
|---|---|---|
| ccatggacatgtctact | agaggaccaggggacat | |
| ctacctggtcaaggtgcaagag | ggtttgaatcttgccactgg | |
| tcctgatggtaagacattccag | gcgtgaacaatcacactcactt | |
| cgtctgtttgtgattcgggg | attcacgccacaggagttgc | |
| agaaggtgaagaggaacagcac | tagatgtatcgagaggggaagc | |
| tcaagaatgcaagggaggcc | aacaggtagaggcgaagtcc | |
| ctatgcttcctggtaacgcg | gcctattattggtggtgccc | |
| tgaaggtcggtgtgaacggatttggc | tgaaggtcggtgtgaacggatttggc |
Fig. 1Analysis of the expression of circadian clock genes in mouse cell lines treated with dexamethasone (Dex). A. RT-PCR analysis of mRNAs encoding Clock proteins expressed by the C2C12, MC3T3-E1, and 10T1/2 cell lines. Cultures were treated with 0–103 nM Dex.
Fig. 2Analysis of the expression of circadian clock genes in primary cultures of osteoblasts of wild-type (WT) and mPer2m/m mice treated with Dex. Top panel. Agarose gel electrophoresis of Clock gene expression in primary osteoblast (pOB) cultures treated with different concentrations of Dex. Bottom panel. Quantitation of mRNA levels normalized to those of Gapdh mRNA (*p < 0.05).
Fig. 3Analysis of the proliferation of osteoblast. A. Proliferation of pOBs of wild-type (WT) and mPer2m/m mice (*p < 0.05). B. Proliferation of MC3T3-E1 cells in the presence and absence of 100 nM each of Dex and zoledronic acid (ZA). Growth medium without supplements (black line), with Dex (blue line), and Dex plus ZA (red line). C. Proliferation of pOBs of WT and mPer2m/m mice after 8 days in culture in the absence or presence (100 nM each) of Dex, ZA, and Dex plus ZA (*p < 0.05).
Fig. 4Morphometric analysis of the fibulae of WT and mPer2m/m treated with ZA. ZA was administered daily for 21 days to WT and mPer2m/m mice injected with slow-release pellets containing prednisolone (PSL). A. μ-CT 3D images of fibulae. Left: sagittal view (upper panel) and axial view (lower panel) of WT mice demonstrating the usual cortical bone and trabeculae. Right: sagittal view (upper panel) and axial view (lower panel) of mPer2m/m mice revealing more thicker cortical bone and smaller trabeculae than those of WT. B. Morphometric analysis of the fibulae of WT and mPer2m/m mice treated with ZA (*p < 0.05).